Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
Expert Opinion on Investigational Drugs
|
January 5, 2002
The use of ranolazine in cardiovascular disease
Richard S Schofield, James A Hill
Pharmacotherapy
|
May 19, 2005
Dilated cardiomyopathy and acute liver injury associated with combined use of ephedra, gamma-hydroxybutyrate, and anabolic steroids
Brychan M Clark, Richard S Schofield
Pharmacotherapy
|
November 5, 2003
The evolving role of nesiritide in advanced or decompensated heart failure
Issam Zineh, Richard S Schofield, Julie A Johnson
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
July 12, 2011
Coronary artery involvement in cardiac amyloidosis
Edlira Maska, Steven M Dorman, Richard S Schofield
Clinical Cardiology
|
April 5, 2011
Coenzyme q10 and creatine in heart failure: micronutrients, macrobenefit?
Mustafa Ahmed, Shawn D Anderson, Richard S Schofield
JAMA Cardiology
|
October 11, 2018
Ensuring Optimal Adjustment for Determinations of Institutional Quality
Javier A Valle, Richard S Schofield, Stephen W Waldo
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
April 3, 2002
Hormone therapy in men and risk of cardiac allograft rejection
Richard S Schofield, James A Hill, Charles J McGinn, et al.
Drugs
|
March 27, 2003
Pharmacological treatment of patients with peripheral arterial disease
Chin K Kim, Carsten M Schmalfuss, Richard S Schofield, et al.
Journal of Clinical Lipidology
|
August 4, 2009
Plasma Coenzyme Q10 Predicts Lipid-lowering Response to High-Dose Atorvastatin
Michael A Pacanowski, Reginald F Frye, Osatohanmen Enogieru, et al.
Pharmacotherapy
|
November 28, 2006
Complementary and alternative medicine use among individuals participating in research: implications for research and practice
Gregory J Welder, Timothy R Wessel, Christopher B Arant, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
Expert Opinion on Investigational Drugs
|
January 5, 2002
The use of ranolazine in cardiovascular disease
Richard S Schofield, James A Hill
Pharmacotherapy
|
May 19, 2005
Dilated cardiomyopathy and acute liver injury associated with combined use of ephedra, gamma-hydroxybutyrate, and anabolic steroids
Brychan M Clark, Richard S Schofield
Pharmacotherapy
|
November 5, 2003
The evolving role of nesiritide in advanced or decompensated heart failure
Issam Zineh, Richard S Schofield, Julie A Johnson
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
July 12, 2011
Coronary artery involvement in cardiac amyloidosis
Edlira Maska, Steven M Dorman, Richard S Schofield
Clinical Cardiology
|
April 5, 2011
Coenzyme q10 and creatine in heart failure: micronutrients, macrobenefit?
Mustafa Ahmed, Shawn D Anderson, Richard S Schofield
JAMA Cardiology
|
October 11, 2018
Ensuring Optimal Adjustment for Determinations of Institutional Quality
Javier A Valle, Richard S Schofield, Stephen W Waldo
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
April 3, 2002
Hormone therapy in men and risk of cardiac allograft rejection
Richard S Schofield, James A Hill, Charles J McGinn, et al.
Drugs
|
March 27, 2003
Pharmacological treatment of patients with peripheral arterial disease
Chin K Kim, Carsten M Schmalfuss, Richard S Schofield, et al.
Journal of Clinical Lipidology
|
August 4, 2009
Plasma Coenzyme Q10 Predicts Lipid-lowering Response to High-Dose Atorvastatin
Michael A Pacanowski, Reginald F Frye, Osatohanmen Enogieru, et al.
Pharmacotherapy
|
November 28, 2006
Complementary and alternative medicine use among individuals participating in research: implications for research and practice
Gregory J Welder, Timothy R Wessel, Christopher B Arant, et al.
Page
of 7